POSB105 Budget Impact Analysis of Introduction of Subcutaneous Infliximab in France from a Payer Perspective
Jan 1, 2022, 00:00
10.1016/j.jval.2021.11.378
https://www.valueinhealthjournal.com/article/S1098-3015(21)02173-2/fulltext
Title :
POSB105 Budget Impact Analysis of Introduction of Subcutaneous Infliximab in France from a Payer Perspective
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)02173-2&doi=10.1016/j.jval.2021.11.378
First page :
Section Title :
Open access? :
No
Section Order :
11159